Foscarnet Sodium通过非竞争性抑制dNTPs而抑制病毒RNA聚合酶,逆转录酶和DNA聚合酶。
Foscarnet Sodium inhibits viral RNA polymerases, reverse transcriptase, and DNA polymerases through noncompetitive inhibition with dNTPs.
0-1.5 mM
5 mM病毒接种48小时后开始,在12小时的时间间隔30μL Foscarnet Sodium局部滴旋,一共处理14天
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Oberg B. Pharmacol Ther, 1989, 40(2), 213-285.
分子式 CNa3O5P |
分子量 191.95 |
CAS号 63585-09-1 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 8 mg/mL |
Water 3 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02151240 | Herpes Zoster | Drug: Foscarnet Sodium|Drug: Acyclovir | Cttq|Peking University People's Hospital | Phase 4 | 2014-05-01 | 2014-05-28 |
NCT00002125 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | Phase 4 | 2005-06-23 | |
NCT00000136 | HIV Infections|Cytomegalovirus Retinitis | Drug: Foscarnet|Drug: Ganciclovir | Johns Hopkins Bloomberg School of Public Health|National Eye Institute (NEI)|Johns Hopkins University|University of Wisconsin, Madison|Baylor College of Medicine|Louisiana State University Health Sciences Center in New Orleans|New York Presbyterian Hospital|Icahn School of Medicine at Mount Sinai|New York University School of Medicine|Northwestern University|University of California, Los Angeles|University of California, San Diego|University of California, San Francisco|University of Miami|University of Massachusetts, Worcester|Memorial Sloan Kettering Cancer Center | Phase 3 | 1990-03-01 | 2015-09-22 |
NCT00002039 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | 2005-06-23 | ||
NCT00002272 | Herpes Simplex|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | 2005-06-23 | ||
NCT00002144 | Herpes Simplex|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | Phase 1 | 2005-06-23 | |
NCT00002432 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | 2005-06-23 | ||
NCT00000726 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-03-28 | |
NCT00002145 | HIV Infections|Gastrointestinal Diseases | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | Phase 3 | 2005-06-23 | |
NCT00002301 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | 2005-06-23 | ||
NCT00000729 | HIV Infections | Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-03-28 | |
NCT00002021 | Herpes Simplex|HIV Infections | Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | 2005-06-23 | ||
NCT00000697 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2012-05-29 | |
NCT00000691 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2012-03-28 | |
NCT00001002 | HIV Infections | Drug: Zidovudine|Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-03-28 | |
NCT00002146 | Cytomegalovirus Infections|HIV Infections|Hypocalcemia | Drug: Magnesium sulfate|Drug: Foscarnet sodium | Astra USA|NIH AIDS Clinical Trials Information Service | Phase 4 | 2005-06-23 | |
NCT00000665 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium|Drug: Ganciclovir | National Institute of Allergy and Infectious Diseases (NIAID)|Johns Hopkins University | 2011-03-11 | ||
NCT00000856 | Encephalopathy|HIV Infections|Radiculitis | Drug: Foscarnet sodium|Drug: Ganciclovir | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-05-29 | |
NCT00000970 | Cytomegalovirus Retinitis|HIV Infections | Drug: Foscarnet sodium|Drug: Ganciclovir | National Institute of Allergy and Infectious Diseases (NIAID)|Astra USA|Hoffmann-La Roche | Phase 1 | 2012-03-29 | |
NCT00000964 | HIV Infections | Drug: Ranitidine hydrochloride|Drug: Foscarnet sodium | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-03-28 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们